Challenges and Changes in the Weight Loss Drug Market

This chapter delves into the obstacles faced in the availability of weight loss drugs, especially compounded semaglutide, and examines the changing strategies of telehealth companies amid regulatory shifts. It concludes with a sponsorship highlight for a podcast focused on executive pay and shareholder influence.